Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 158

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 158
---
On October 23, 2023, the
Company issued 1,000,000shares
of Common Stock valued at $2,760,000 for advisory services to Avram Miller, a member of the Company’s board of directors.

Between July 28, 2023, and
September 28, 2023, the Company issued 2,000,000
shares of Common Stock for consulting services valued at $4,470,000.

On June 26, 2023, the Company issued 4,718,532shares of Common Stock and warrants to purchase 2,359,266shares of common stock resulting in proceeds of $ 1,300,823in a private placement offering and the reduction of notes payable of $1,200,000. The warrants were immediately
exercisable and had an exercise term of five years with an exercise price of $0.53 per share. The combined purchase price for one share
of Common Stock and one warrant was $0.53 per share.

On June 26, 2023, the Company issued 4,718,532shares of Common Stock and warrants to purchase 2,359,266shares of common stock resulting in proceeds of $ 1,300,823in a private placement offering and the aforementioned reduction of notes payable of $1,200,000. The
warrants were immediately exercisable and had an exercise term of five years with an exercise price of $0.53 per share. The combined purchase
price for one share of Common Stock and one warrant was $0.53 per share.

On June 20, 2023, the Company issued
696,021 shares of Common Stock to Lincoln Park as a commitment fee as part of a purchase agreement.

On April 27, 2023, there were 100,000
shares issued that immediately vested and were converted into shares of Common Stock in exchange for consulting services valued at $120,000.

F-28

During March 2023, the Company issued 2,378,070shares of Common Stock and warrants to purchase 1,189,036shares of Common Stock resulting in proceeds of $ 2,711,000in a private placement offering. The Company effected the issuances of the shares of Common Stock from March 13, 2023 to March 29, 2023. The purchase warrants were immediately exercisable and had an exercise term of five years with an exercise price of $ 1.14per